🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nan Lin

Regeneron (United States)

ORCID: 0000-0002-1659-7521

Also affiliated with Sichuan University, Affiliated Hospital of Jining Medical University, State Key Laboratory of Biotherapy

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies”.

A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgz326

N/A

0.626DataRank · unranked

64 citations

Ky’Era V. Actkins, Jennifer A. Pacheco, Anna O. Basile, Robert J. Carroll, David R. Crosslin +66 more

Risk of lymphoid malignancy associated with cancer predisposition genes

Blood Cancer Journal(2025)10.1038/s41408-025-01283-z

N/A

0DataRank · unranked

8 citations

Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison Rosenthal, Thomas M. Habermann +95 more

Exclusion-based exome sequencing in critically ill adults 18–40 years old has a 24% diagnostic rate and finds racial disparities in access to genetic testing

The American Journal of Human Genetics(2025)10.1016/j.ajhg.2025.06.007

N/A

0DataRank · unranked

5 citations

Colleen Morse Kripke, Adam J. Mansfield, Alexander Li, Alexander Lopez, Alicia Hawes +95 more